As described previously for renal cell cancer patients (Vroling et al, 2009), two distinct CD34+ cell populations, which differ in the expression of the leucocyte marker CD45 and progenitor marker CD133, were identified in NSCLC patients. This evidence concerns the gene CD34 and non-small cell lung carcinoma.